Screener / Antibody Engineering & Oncology / Chugai Pharmaceutical Co
4519 · TSE
Chugai Pharmaceutical Co
Compliant
Under AAOIFI Standard 21, Chugai Pharmaceutical Co is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.
Ticker4519
ExchangeTSE
SectorAntibody Engineering & Oncology
Full ratios for Chugai Pharmaceutical Co (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding Chugai Pharmaceutical Co or any other security.